• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal
  • A Prospective, Non Interventional Study to Evaluate he Effects on Quality of Life, Symptoms and Productivity in Patients With Gastroesophageal Reflux Disease (GERD) After 6 Weeks Structured Treatment in a occupational Health Care Setting

Disease
acid reflux
Drug Name
non drug study (gastrointestinal)
Generic Name
No Drug
Sponsor
AstraZeneca
Drug Status
In Development
Phase
Non-Interventional Study
Start Date
Apr 16, 2009
Study Name
NIS-GSE-DUM-2009/1
Study Id
NIS-GSE-DUM-2009/1
ClinicalTrials.gov ID
NCT00884247
Recruiting Status
Closed
Protocol Status
Not Available
Report
May 3, 2010
  • NIS-GSE-DUM-2009_1.pdf (174 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013